Page last updated: 2024-12-08

laminaran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-1,3-glucan: component of fungal cell walls; also used as antitumor polysaccharide; unspecified D usually means BETA-GLUCANS; beta-1,3-D-glucan is also available; glucan phosphate is also available; biosynthesis is inhibited by echinocandins (cyclic hexapeptides) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

laminarin : A polysaccharide composed of beta-(1->3)-linked glucose residues containing sporadic beta-(1->6)-linkages as branch points or inter-residue linkages and 2-3% D-mannitol at some reducing termini. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

laminaran: beta-1,3-glucan [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID439306
SCHEMBL ID156574
MeSH IDM0051935
PubMed CID455149
MeSH IDM0051935

Synonyms (18)

Synonym
beta-1,3-glucan
laminarin
(3r,4s,5r,6r)-4-[(3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol
einecs 232-712-4
iodus 40
beta-d-glucan, (1->3)-
SCHEMBL156574
mfcd00466918
laminaran (from eisenia bicyclis)
Q423729
(3r,4s,5r,6r)-4-(((3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-2,3,5-triol
(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol
A860910
9008-22-4
laminaran
o-b-d-galactopyranosyl-(1->3)-o-b-d-galactopyranosyl-(1->3)-d-galactose, 9ci
hexopyranosyl-(1->3)hexopyranosyl-(1->3)hexopyranose
DTXSID40864163

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Elimination half-life was longer (3."( Pharmacokinetics of fungal (1-3)-beta-D-glucans following intravenous administration in rats.
Adams, EL; Barker, LA; Ensley, HE; Lockhart, BE; Rice, PJ; Williams, DL, 2004
)
0.32
" A pharmacokinetic model was developed to describe uptake, and modelling was performed using ADAPT 5 software."( Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages.
Dube, A; Gouveia, L; Hayeshi, R; Naicker, B; Paixao, P; Tukulula, M, 2018
)
0.48
" Elimination half-life was longer (3."( Pharmacokinetics of fungal (1-3)-beta-D-glucans following intravenous administration in rats.
Adams, EL; Barker, LA; Ensley, HE; Lockhart, BE; Rice, PJ; Williams, DL, 2004
)
0.32

Compound-Compound Interactions

ExcerptReferenceRelevance
"To evaluate serum antigens assay combined with chest CT scan in the diagnosis of patients of invasive pulmonary aspergillosis (IPA) without neutropenia."( [Serum antigens assay combined with chest CT scan in diagnosis of invasive pulmonary aspergillosis].
Shen, P; Xu, PF; Zhou, H; Zhou, JY, 2012
)
0.38
" The specificity of GM assay combined with chest CT was 100."( [Serum antigens assay combined with chest CT scan in diagnosis of invasive pulmonary aspergillosis].
Shen, P; Xu, PF; Zhou, H; Zhou, JY, 2012
)
0.38
"The GM assay combined with chest CT may increase the specificity of diagnosis for IPA patients without neutropenia."( [Serum antigens assay combined with chest CT scan in diagnosis of invasive pulmonary aspergillosis].
Shen, P; Xu, PF; Zhou, H; Zhou, JY, 2012
)
0.38
" We undertook a meta-analysis of 13 studies involving 1513 patients to evaluate the utility of GM in combination with BDG or LFD for diagnosing IA."( The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies.
Chen, G; Feng, J; Guo, Z; Huang, Y; Xie, S; Zhang, L; Zhou, J, 2019
)
0.51

Bioavailability

ExcerptReferenceRelevance
" Hence, inflammatory diseases may impose variability in drug bioavailability through alterations in the intestinal expression and activity of drug transporters."( Changes of Absorptive and Secretory Transporting System of (1 → 3) β-D-glucan Based on Efflux Transporter in Indomethacin-induced Rat.
Aketagawa, J; Hayashi, M; Iida, A; Ito, Y; Oda, T; Ouchi, S; Takizawa, Y; Tomita, M, 2015
)
0.42
"Curcumin (CUR) is a promising natural compound in ulcerative colitis (UC) treatment, but limited by its low oral bioavailability and poor targeting ability."( Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
Ayue, S; Chang, D; Dai, L; Gao, F; He, H; Luo, R; Qi, S; Ye, N; Ye, Y; Zhao, P, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" Pustulan, presumed to be a beta (1-->6)-glucan, showed a parallel dose-response curve at concentrations 10 times higher than that of laminarin."( Measurement of beta(1-->3)-glucans in occupational and home environments with an inhibition enzyme immunoassay.
Brunekreef, B; Doekes, G; Douwes, J; Heederik, D; Montijn, R, 1996
)
0.29
" Here, we investigated the clearance of glucans from the blood following multiple dosing using MRL lpr/lpr mice with an autoimmune disease."( Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.
Aketagawa, J; Miura, NN; Ohno, N; Tamura, H; Tanaka, S; Yadomae, T, 1996
)
0.29
" Dose-response relationships among personal exposures and percentage cross-shift decrease in lung function and percentage predicted lung function were more pronounced among joinery workers compared with sawmill and chip mill workers."( Work-related symptoms and dose-response relationships for personal exposures and pulmonary function among woodworkers.
Alwis, KU; Hocking, AD; Mandryk, J, 1999
)
0.3
" Higher dosage of three genes, BEM1, LRG1, and FUS1, partially suppressed the fus2Delta cell fusion defect."( Lrg1p Is a Rho1 GTPase-activating protein required for efficient cell fusion in yeast.
de Candal, VB; Fitch, PG; Gammie, AE; Lee, DJ; Rose, MD, 2004
)
0.32
" Increased dosage of beta-glucan from 2 to 10gkg(-1) diet did not affect the expressions of the genes, indicating the sufficiency of beta-glucan supplementation at 2gkg(-1) diet."( Differential time-series expression of immune-related genes of Pacific white shrimp Litopenaeus vannamei in response to dietary inclusion of beta-1,3-glucan.
Chang, PS; Chen, HY; Wang, YC, 2008
)
0.35
" Dose-response data for the biological components present in the dust encountered at composting sites are not well established at this time and site operators should adopt precautionary measures when assessing and managing these potential risks."( Workers' exposure to dust, endotoxin and β-(1-3) glucan at four large-scale composting facilities.
Allen, JA; Jones, KP; Morris, RH; Sykes, P; Wildsmith, JD, 2011
)
0.37
"2 demonstrated induction of these defence-related responses at each UV-C dosage tested."( Sub-lethal UV-C radiation induces callose, hydrogen peroxide and defence-related gene expression in Arabidopsis thaliana.
Cahill, DM; Mintoff, SJ; Rookes, JE, 2015
)
0.42
" The hydrolytic activity and the amount of Candida antarctica lipase B (CALB) displayed on cell surface increased significantly following optimization of the fusion gene dosage and combination of the homogeneous or heterogeneous cell wall proteins."( Accurate analysis of fusion expression of Pichia pastoris glycosylphosphatidylinositol-modified cell wall proteins.
Chen, M; Fisher, R; Han, S; Liang, S; Lin, Y; Sui, H; Wang, P; Zhang, L; Zheng, S, 2017
)
0.46
" This trail included 2 factors: the dosage of β-1,3-glucan (0, 100 g/T, and 200 g/T) and feeding condition (HS and normal)."( Effect of dietary β-1,3-glucan supplementation and heat stress on growth performance, nutrient digestibility, meat quality, organ weight, ileum microbiota, and immunity in broilers.
Kim, IH; Luo, Z; Ou, J; Zhang, S, 2020
)
0.56
" Compared with a one-time LA dosing strategy, the pollutant removal capacity of batch dosing was superior."( Application of laminarin as a novel coagulant aid to improve coagulation-ultrafiltration efficiency.
Jia, W; Liu, M; Yan, Y; Yang, W; Zhang, J; Zhao, S, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Professional Supplements1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
DaVinci Laboratories Immuno-DMG with Elderberry & Vitamin D3 -- 120 Chewable TabletsDaVinci LaboratoriesProfessional SupplementsVitamin C, Vitamin D3, Vitamin E, N, Vitamin E, Beta 1,3 Glucan2024-11-29 10:47:42

Research

Studies (1,210)

TimeframeStudies, This Drug (%)All Drugs %
pre-199080 (6.61)18.7374
1990's264 (21.82)18.2507
2000's368 (30.41)29.6817
2010's385 (31.82)24.3611
2020's113 (9.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.34 (24.57)
Research Supply Index6.75 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index76.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials20 (2.40%)5.53%
Trials10 (2.23%)5.53%
Reviews65 (7.81%)6.00%
Reviews18 (4.01%)6.00%
Case Studies20 (2.40%)4.05%
Case Studies1 (0.22%)4.05%
Observational1 (0.12%)0.25%
Observational0 (0.00%)0.25%
Other726 (87.26%)84.16%
Other420 (93.54%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]